Skip to main content
. 2015 Nov 26;16(12):28126–28145. doi: 10.3390/ijms161226087

Table 6.

Tenofovir treatment for chronic hepatitis B with severe acute exacerbation.

Authors Design Treatment (Patient Number) HBV DNA (IU/mL) Mortality (%) p-Value Prognostic Factors
Garg et al. [69] Randomized study TDF (14) 7.5 × 105 43% 0.03 >2 log reduction in HBV DNA at 2 weeks
Cotnrol group (13) 1.7 × 106 85%

TDF: tenofovir.